Bookmark Article
A leaked report reveals that British cancer patients are suffering due to Brexit-related delays, which prevent access to life-saving drugs and disrupt clinical trials for innovative treatments. As cancer diagnoses rise amidst an ageing population and enhanced awareness, the need for global collaboration in developing new medicines has become increasingly crucial. The report underscores the human cost of these clinical trial setbacks, emphasizing that “children with cancer cannot wait” for timely access to essential treatments.
